We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Similar to the functionality of workplace pensions, employees can invest part of their pay into an ISA and start to build a healthy saving habit. Smarterly's current clients include Rolls Royce, Samsung and OVO Energy and they have identified 85 other organisations with a collective 600,000 employees as potential opportunities. Due to the fundamentals of Smarterly being automated, there is no need to pay for a large staff and revenue is generated via small fees.
days to go: Expired investment: £1,638,150
Baanx is a Business to Business to Consumer (B2B2C) banking platform that is Application Programming Interface (API) driven and digital-friendly. It aims to become a contender in the digital asset financial services market that is expected to rise and expand to over 580 million people or 7+% of the world population by 2022. Baanx argues that it is disrupting the slow and expensive banking sector by leveraging blockchain to launch secure and low-cost banking products and services, with a few lines of code. Baanx offers its users 'Digital wallets' (via API or a custom mobile app), crypto-friendly debit cards in physical and virtual formats, and allows users to send fiat or cryptocurrencies to anyone in their contact list with 'zero' Foreign Exchange (FX) fees, through its proprietary software, TextBit.  
days to go: Expired investment: £9,500,000
Ignite 100 is a 13 week accelerator program for early stage technology companies. Ignite look for unique, interesting people and help them to look at what they are trying to do with their company, who their target audience is and then introduce them to entrepreneurs that have previously been in the same situation. 
days to go: Expired investment: £351,310
E-RIDER sell electric bikes and scooters and is a new concept in personal travel. The E-RIDER bikes and scooters glide over the road with all the convenience of a silent motorcycle. All of the E-RIDER bikes and scooters come with a brake light, audible indicators, wing mirrors and motorbike suspension and these all allow for a more comfortable, safer ride.
days to go: Expired investment: £4,550
Website: www.riskrewardlimited.com Risk Reward Ltd is a global banking and financial services training, consultancy and recruitment specialist that operates from its offices in London and recently opened a second office in Miami to service its business in the Americas. The company specialises in risk and compliance training and recruitment, the fastest growing part of the sector. The business is raising equity investment for the first time in its 13-year history, giving investors the first opportunity to become part of this successful and fast growing business. Established in 2002, Risk Reward’s client list has evolved to incorporate the names of national and international banks, leading financial services companies and insurance firms spanning five continents. Clients include international training firms and specific banks including the British Bankers Association, GPS, MIS, Al Rajhi Bank, FBN, First Gulf Bank, HSBC, Lloyds Bank, Wells Fargo and many more prominent names. Several growth-spurring developments are happening simultaneously to lead the company to offer 5% in its market-leading business to new investors: * Exceptional growth in its training business; the company has developed its retail training business in London and Dubai, and has also developed its multi-lingual global training services * Investment has been made in development of a new recruitment businesses which is now approved by a number of companies and has been followed by taking over the business of Buckley Alan, a 12 year old recruitment firm * Recently opened a US office in Miami * Developed a learning management system which is successfully installed in a major bank and links skills to training delivery * Published two best-selling money laundering deterrence works and a major text on business mathematics * Approved by 5 major institutes to offer their training products including the CISI, ICAEW and ACAMS Sales vary month on month between £150,000 and £200,000, and recent unsolicited valuations have put the company’s worth between £7-12 million. These valuations also took into account the level of investment written off during the year developing the learning management system, recruitment business and US office. Business growth is around 25% per annum in this fast growing sector. The fast-moving business requires equity investment to fuel its growth as the company strives to develop its already-strong position as a technical leader in its space. This pitch represents an opportunity to invest in a respected training and recruitment business with a wealth of prominent clients.
days to go: Expired investment: £25,300
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go: Expired investment: Withheld
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph